INTRODUCTION 41
C-terminal tensin-like (Cten, also known as tensin4) is the member of the tensin gene family which 42 comprises four members (tensin1, tensin2, tensin3, and Cten/tensin4). This protein family localises to the 43 cytoplasmic tails of integrins at focal adhesion sites. Cten shares high sequence homology to the C-terminus 44 of the other tensins with a common Src homology 2 (SH2) domain and phosphotyrosine binding (PTB) 45 domain. Unlike the other tensin protein members (tensins 1-3), Cten lacks the actin binding domain (ABD) 46 3 which results in an inability to bind to the actin cytoskeleton and is thought to play a critical role in cellular 47 processes such as cell motility (1) . 48 49 Cten is a putative biomarker in many cancers, acting as oncogene in most tumour types including 50 the colon, breast, pancreas and melanoma, and it is particularly associated with metastatic disease (2). Cten 51 expression is possibly upregulated through the activation of upstream signalling pathways since so far, no 52 mutations or amplification of Cten in cancers have been documented. A study by Katz et al. showed that 53 stimulation with EGF led to upregulated Cten expression at a post-transcriptional level only in breast cell 54 lines, whereas others have shown that Cten is upregulated by the EGFR at both the transcriptional and post-55 transcriptional level (3, 4) . Further reports suggested that Cten is regulated by KRAS in both CRC and 56 pancreatic cancer cells (5). Cten expression was also shown to be negatively regulated by STAT3 in CRC 57 cell lines, whereas others have found that Cten is upregulated by STAT3 in human lung cancer cells (6, 7) . 58
How Cten is activated and regulated in these tumours is unclear, nonetheless, multiple pathways seem to 59 be involved, and it appears to be largely dependent on tissue type or context. 60
Transforming growth factor beta 1 (TGF-β1) is a polypeptide member of the growth factor family 61 that plays a physiological role in the regulation of wound healing, angiogenesis, differentiation, and 62 proliferation. TGF-β 1 can function as a tumour suppressor in normal epithelial cells and in the early stage 63 of cancer. However, the growth inhibitory function of TGF-β1 is selectively lost in late stage cancer which 64 results in an induction of cell migration, invasion and metastasis (8, 9) . Previous studies have shown that 65 TGF-β1 is involved in the regulation of EMT processes through numerous downstream pathways, including 66 Ras/MAPK (10), RhoA (11), and Jagged 1/Notch (12). TGFβ1 has also been found to signal through FAK 67 to upregulate EMT related mesenchymal and invasiveness markers and delocalise E-cadherin membrane 68 (13). TGF-β1 has been shown to regulate several integrins including αV, β1, and β3 in glioblastoma, 69 fibroblast, and kidney epithelial cells (14) . Others have suggested that the positive regulation of integrin of 70 αV, α6, β1, and β4 by TGF-β1 signalling is probably mediated via the activation of the TGF-β1/TGF-71 6 was then lysed in ice-cold CER I supplemented with protease inhibitor for 10 minutes, followed by addition 124 of ice-cold CER II and incubation on ice for 1 minute. Cell lysates were then centrifuged at 16,000 x g for 125 5 minutes at 4°C and the supernatant containing cytoplasmic proteins was removed and stored for use. The 126 insoluble pellet was resuspended in ice-cold NER supplemented with protease inhibitor and incubated on 127 ice for 40 minutes and then centrifuged at 16,000 x g for 5 minutes at 4°C. Next, the supernatant containing 128 nuclear fractions was transferred to a clean, pre-chilled tube. Thereafter, western blotting was performed as 129 previously described. Table 2 ). Then, cells were washed three times in PBS 138 for 5 minutes each and incubated with Alexa Fluor 488 (green) or Alexa Fluor 568 (17) secondary antibody 139 (Thermo Fisher Scientific) diluted in 1% BSA+PBS-T with gentle rotation at room temperature in the dark 140 for 60 minutes. Cells were then washed three times in PBS-T for 5 minutes in the dark and incubated with 141 1x DAPI (1:5000) (Sigma) in PBS with gentle rotation for 30 minutes. Following this, cells were again 142 washed a further 2 times in PBS for 5 minutes in the dark and mounted with a drop of fluorescein mounting 143 media (Sigma) on glass slides. The cells were viewed using the Leica Microsystems confocal microscope 144 at x40 objective and Leica Application Suite X software was used for image acquisition. The changes in cell migration were assessed in 24 well plates using the Transwell system (Corning, 158 Corning, NY). Cells were treated with mitomycin C (10 µg/ml) for 3 hours and washed 3 times with PBS 159 to inhibit cell proliferation. The Transwell inserts (6.5 mm diameter; 8 μm pore size) were incubated in 160 DMEM at 37°C for 1 hour prior to use. Following this, 600 μl of DMEM (20% FBS) was added to the outer 161 wells of the Transwell plate and the Transwell inserts placed inside. A total of 1 × 10 5 cells in DMEM (10% 162 FBS) were seeded onto the Transwell insert. The plate was incubated at 37°C for 24 hours. Following this, 163 the cells that had migrated through to the bottom of the outside well, using the higher FBS concentration as 164 a chemoattractant, were manually counted. Triplicate wells were seeded for each experimental condition. 165
The Transwell invasion assay was performed according to this protocol with the exception that 2 × 10 5 cells 166 were seeded onto a Transwell insert coated in matrigel reduced growth factor (0.3 mg/ml, Corning) and 167 cells allowed to migrate for 48 hours prior to counting. 168
169

Wound Healing 170
Wound healing" scratch assay was performed as an alternative assay to assess cell migration. 171
Briefly, 5-7 x 10 5 cells /ml were seeded into culture-insert 2 well (Ibidi) attached in 6 well plates and 172 incubated for 24 hours at 37°C until they reached confluency. After cell attachment, the culture inserts were 173 removed, and the cells were treated with mitomycin C (10 µg/ml) for 3 hours to inhibit proliferation. Cells 174 were cultured under normal conditions, and the pictures were taken at time points 0, 24, or 48 using an 
Statistical Analysis 181
Results were tested for a normal distribution, and the unpaired t-test or analysis of variance 182 (ANOVA) statistical tests were applied using GraphPad Prism (version 6). 183
184
RESULTS
185
TGF-β1 Regulates Cten Expression 186
Both TGF-β1 and Cten induce EMT and cell motility and are associated with integrin signalling. 187 Cten is normally located at focal adhesions but we and others have shown that there is also nuclear 219 localisation (although the significance of this is uncertain). Since TGF-β1 signalling may be mediated 220 through Cten, it was of interest whether TGF-β1 is capable of inducing Cten protein translocation to the 221 nucleus. HCT116 cells were stimulated with TGF-β1 and the expression of Cten and its downstream targets 222 in nucleus were observed by immunofluorescences staining ( Figure 5A ). The results showed that 223 stimulation of HCT116 cell with TGF-β1 for 48 h induced Cten, Src, ROCK, and Snail protein expression 224 as well as translocation to the nucleus. In contrast, in untreated HCT116 cells, there was no Cten or its 225 downstream target proteins detected in the nucleus ( Figure 5A ). To validate these data, TGF-β1 was used 226 to stimulate the SW620 cell line and both immunofluorescence staining and nuclear and cytoplasmic 227 extraction were performed to directly determine the subcellular localisation of Cten and its downstream 228 targets: Src, ROCK1, and Snail proteins. Subcellular fractionation experiments showed an increase in the 229 nuclear fraction of Cten, Src, ROCK1, or Snail proteins following treatment with TGF-β1 (Figure 4) . 230
Immunofluorescence imagining showed that, as with HCT116, stimulation of SW620 with TGF-β1 231 treatment increased the expression and nuclear translocation of Cten, ROCK1, Src, and Snail compared to 232 the untreated cell control ( Figure 5B) . 233
To investigate whether Cten was essential for TGF-β1 induced the nuclear translocation of Src, 234 ROCK and Snail proteins through Cten, the cell line SW620 of EMT. We also showed that TGFβ1 signalling induces cell motility (both migration and invasion). Since 244 these Cten induces EMT and cell motility, it is reasonable to hypothesise that Cten in a direct mediator of 245 TGFβ1 activity. We have previously described the creation of SW620 ΔCten (16) . This is derivative of SW620 246 in which Cten has been deleted using CRISPR/Cas9 technology. In order to test our hypothesis, SW620 ΔCten 247 was stimulated with TGFβ1and Western blotting was performed. The results revealed that stimulation with 248 with TGF-β1 was associated with a small increase in N-cadherin expression but ROCK1, Src, Snail, and E-249 cadherin protein expression level remained unchanged compared to the sham-treated cells control (Figure  250 6 A). This implies that Cten is may be responsible for TGF-β1 induced EMT. 251
To determine if Cten was functionally relevant to TGF-β1 mediated activity, SW620 shown to act as oncogene in most tumour types and involved in regulation of EMT processes, however, the 265 mechanisms that upregulate the expression of Cten induced EMT have not been elucidated (16, (19) (20) (21) . 266
Previous research from our laboratory suggested that Cten expression is regulated by EGFR/KRAS 267 signalling (5) and the study by Katz et al (3) showing the role of Her2 in up-regulating Cten would seem to 268 validate this. We and others further have also found that Cten could be under the regulation of several 269 cytokines such as IL6/Stat3 and growth factors (6, 22) . The present study directly shows, for the first time 270
an essential role for Cten in TGF-β1-induced EMT and cell motility in CRC cells and that this may be 271 through upregulation of the Src/ROCK1/Snail signalling pathway. 272 TGF-β1 reputedly plays a key role in promoting EMT initiation and tumour metastasis. In the latest 273 classification of CRCs (25), the most aggressive class (CMS4) is characterised by TGF-β activation. It has 274 been documented that TGF-β1 induces the expression of several transcription factors including Twist, Zeb, 275 Slug, and Snail (23). Here, using different methods of modulating TGF-β1 activity, we have shown that 276 TGF-β1 is a positive regulator of Cten expression. We have also shown that TGF-β1 is a positive regulator 277 of Src, ROCK, and Snail expression. Since these are putative targets of Cten, it begs the question whether, 278 in this case, they are directly up-regulated by TGF-β1 signalling or whether they are up-regulated by Cten12 as a secondary event. Using the SW620 ΔCten cell line (in which Cten is deleted) we were able to conclusively 280
show that up-regulation of these molecules is Cten-dependent. We observed, by both immunofluorescence 281 and cellular fractionation, that TGF-β1 signalling induced nuclear localisation of Cten as well as Src, 282 ROCK, and Snail. We were similarly able to show that nuclear localisation of Src, ROCK, and Snail was 283
Cten-dependent. The mechanisms by which these proteins are up-regulated and by which their cellular 284 location is controlled are uncertain although we have previously shown that Cten causes post-translational 285 stabilisation of Snail (16). The link between TGF-β1 and Cten may be through integrins since TGF-β1 286 induces integrin activation and Cten is found in compelxt with the cytoplasmic tail of integrins. However 287 there are also several other downstream targets of TGF-β1 mediated EMT which may possibly be involved 288 in regulation of Cten and further investigation of markers/signalling pathways such as Ras/MAPK (10), 289
RhoA (11), and Jagged 1/Notch (12) is warranted. 290
Our data suggest a novel downstream signalling pathway for TGF-β1 which is mediated through 291
Cten. In order to ascertain whether this represented a functionally relevant pathway, we performed assays 292 to assess motility (both by invasion and migration assays) and cell proliferation. In our models, TGF-β1 293 signalling was shown to increase cell proliferation, migration (both transwell migration and wound healing) 294 and cell invasion. These data are in accordance with previous studies that TGF-β1 induced EMT can 295 promote cell motility and proliferation in a vast range of different tumour cells such as breast cancer and 296 oral squamous cell carcinoma (24, 26). Intuitively one would think that the induction of cell motility was 297 mediated through the Cten pathway. This was confirmed by our observation that there was a selective loss 298 of the effect of TGF-β1 treatment on both cell migration and invasion in the SW620 ΔCten cell line while the 299 effect of TGF-β1 treatment on cell proliferation was unaffected. This is completely in line with our previous 300 data showing that Cten regulates cell motility and does not affect cell proliferation (19) . 301
It is not unexpected that TGF-β1will activate different signalling pathways to regulate different 302 cellular functions. Our data show that the Cten pathway is an important factor in the TGF-β1 regulation of 303 cell motility and they may explain other observations that have been made. Thus previous published data 304 from our group have shown that Cten induces EMT and promotes cell motility through FAK, ILK and Snail 305 13 signalling (16, 21, 27) . Others have shown that FAK and/or ILK are required for TGF-β1 induced EMT 306 and to promote cell motility (13, 28) . Snail also has been shown to act as a mediator of TGF-β1 induced 307 EMT(29). We would now hypothesise that Cten is one of the missing links which would explain 308 
